Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

Natco Pharma informs about analyst meet

Date: 16-11-2023
Pursuant to Regulation 30 & 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to intimation letter dated 9th November, 2023, Natco Pharma has informed that the audio recording of the earnings call for the quarter and half year ended 30th September 2023, held on 15th November, 2023 at 11.00 Hrs IST have been uploaded on website at the following weblink: https://www.natcopharma.co.in/wp-content/uploads/2023/11/Q2FY24earningscall.mp3

The above information is a part of company’s filings submitted to BSE.